Hemophagocytic syndrome in a patient with Fanconi anemia and VACTERL association

Main Article Content

Maria Luiza Rocha da Rosa Borges
Victor Coentro Torreiro de Moraes
João Lucas Cruz Souza
Edinalva Pereira Leite
Neide Santos
Terezinha de Jesus Marques-Salles

Abstract

Introduction: Hemophagocytic syndrome results from hyperactivity of histiocytes and lymphocytes, triggered by infections, mainly viral by cytomegalovirus, Epstein-Barr and herpes. Fanconi anemia (FA) is a rare genetic disease with heterogeneous symptoms common to other diseases such as VACTERL, a disease of unknown etiology in which there are several congenital malformations. The concomitance of Fanconi and VACTERL anemia occurs in 5 to 30% of FA patients. Report: A 14-month-old male infant was admitted to investigate fever, hepatosplenomegaly, and granulopenia. The patient was diagnosed with hemophagocytic syndrome due to hyperferritinemia, bone marrow hemophagocytosis, transaminase elevation, decreased fibrinogen, and cytomegalovirus (CMV) infection confirmed by serology and PCR. The test with mitomycin C (MMC) showed chromosomal fragility. The patient was diagnosed with a VACTERL/FA association for having a clinic and a test compatible with both FA and VACTERL. Conclusion: The VACTERL/FA association is seldom described, but is present in pediatric medical practice. This study presented the main clinical-laboratory aspects and reviewed the main aspects of the concurrence of this pathology.


 


 


 


 

Downloads

Download data is not yet available.

Article Details

How to Cite
Borges, M. L. R. da R., Moraes, V. C. T. de, Souza, J. L. C., Leite, E. P., Santos, N., & Marques-Salles, T. de J. (2022). Hemophagocytic syndrome in a patient with Fanconi anemia and VACTERL association. ABCS Health Sciences. https://doi.org/10.7322/abcshs.2021021.1750
Section
Reports

References

Zen PRG, Moraes FN, Rosa FRM,Graziadio C, Paskulin GA. Características clínicas de pacientes com anemia de Fanconi. Rev Paul Pediatr. 2011;29(3):392-9. https://doi.org/10.1590/S0103-05822011000300014

Dufour C. How I manage patients with Fanconi anemia. Br J Haematol. 2017;178(1):32-47. https://doi.org/10.1111/bjh.14615

Schneider M, Chandler K, Tischkowitz M, Meyer S. Fanconianaemia: genetics, molecular biology, and cancer-implications for clinical management in children and adults. Clin Genet. 2014;88(1):13-24. https://doi.org/10.1111/cge.12517

Soulier J. Fanconi anemia. Hematol Am Soc Hematol Educ Program. 2011;2011:492-7. https://doi.org/10.1182/asheducation-2011.1.492

Deng W, Zhao M, Liu Y, Cao L, Yang M.Fanconi anemia in twins with neutropenia: a case report. Oncol Lett. 2018;16(4):5325-30. https://doi.org/10.3892/ol.2018.9304

Fiesco-Roa MO, Giri N, McReynoldsLJ, Best AF, Alter BP.Genotype-phenotype associations in Fanconi anemia: a literature review. Blood Rev. 2019;37:100589. https://doi.org/10.1016/j.blre.2019.100589

Alter BP, Rosenberg PS. VACTERL-H Association and Fanconi anemia. Mol Syndromol. 2013;4(1-2):87-93. https://doi.org/10.1159/000346035

Solomon BD, BakerLA, Bear KA, Cunningham BK, Giampietro PF, Hadigan C, et al. An Approach to the Identification of Anomalies and Etiologies in Neonates with Identifiedor Suspected VACTERL (Vertebral Defects, Anal Atresia, Tracheo-Esophageal Fistula with Esophageal Atresia, CardiacAnomalies, Renal Anomalies, andLimbAnomalies) Assoc J Pediatric. 2014;164(1):451-7. https://doi.org/10.1016/j.jpeds.2013.10.086

Liu Y, Ballman K, Li D, Khan S, Derr-Yellin E, Shou W, et al. Impaired function of Fanconi anemia type C-deficient macrophages. J Leukoc Biol. 2012;91(2):333-40. https://doi.org/10.1189/jlb.0811418

Guerrero-González GA, Martínez-Cabriales SA, Hernández-Juárez AA, Lugo-Trampe JJ, Espinoza-González NA, Gómez-Flores M, et al. Rothmund-Thomson Syndrome: A 13-Year Follow-Up. Case Rep Dermatol. 2014;6(2):176-9. https://doi.org/10.1159/000365625

Alter BP,Giri N. Thinking of VACTERL-H? Rule out Fanconi anemia according to PHENOS. Am J Med Genet. 2016;170(6):1520-4. https://doi.org/10.1002/ajmg.a.37637

Porteous ME, Cross I, Burn J. VACTERL with hydrocephalus: One end of the Fanconi anemia spectrum of anomalies? Am J Med Genet. 1992;43(6):1032-4. https://doi.org/10.1002/ajmg.1320430624

Giampietro PF, Adler-Brecher B, Verlander PC, Pavlakis SG, Davis JG, Auerbach AD. The need for more accurateandtimelydiagnosis in Fanconi anemia: a report from the International Fanconi Anemia Registry. Pediatrics. 1993;91(6):1116-20.

Faivre L, Portnoï MF, Pals G, Stoppa-Lyonnet D, Le Merrer M, Thauvin-Robinet C, et al. Should chromosome breakage studies be performed in patientswith VACTERL association? Am J Med Genet. 2005;137A(1):55-8. https://doi.org/10.1002/ajmg.a.30853

Botto LD, Khoury MJ, Mastroiacovo P, Castilla EE, Moore CA, Skjaerven R, et al. The spectrum of congenital anomalies of the VATER association: aninternational study. Am J Med Genet. 1997;71(1):8-15. https://doi.org/10.1002/(SICI)1096-8628(19970711)71:1<8::AID-AJMG2>3.0.CO;2-V